Microscopic kinetics and energetics distinguish GABAA receptor agonists from antagonists

被引:76
|
作者
Jones, MV
Jonas, P
Sahara, Y
Westbrook, GL
机构
[1] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA
[2] Tokyo Med & Dent Univ, Dept Maxillofacial Biol, Tokyo 113, Japan
[3] Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany
[4] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
关键词
D O I
10.1016/S0006-3495(01)75909-7
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Although agonists and competitive antagonists presumably occupy overlapping binding sites on ligand-gated channels, these interactions cannot be identical because agonists cause channel opening whereas antagonists do not. One explanation is that only agonist binding performs enough work on the receptor to cause the conformational changes that lead to gating. This idea is supported by agonist binding rates at GABAA and nicotinic acetylcholine receptors that are slower than expected for a diffusion-limited process, suggesting that agonist binding involves an energy-requiring event. This hypothesis predicts that competitive antagonist binding should require less activation energy than agonist binding. To test this idea, we developed a novel eleconvolution-based method to compare binding and unbinding kinetics of GABAA receptor agonists and antagonists in outside-out patches from rat hippocampal neurons. Agonist and antagonist unbinding rates were steeply correlated with affinity. Unlike the agonists, three of the four antagonists tested had binding rates that were fast, independent of affinity, and could be accounted for by diffusion- and dehydration-limited processes. In contrast, agonist binding involved additional energy-requiring steps, consistent with the idea that channel gating is initiated by agonist-triggered movements within the ligand binding site. Antagonist binding does not appear to produce such movements, and may in fact prevent them.
引用
收藏
页码:2660 / 2670
页数:11
相关论文
共 50 条
  • [41] Participation of GABAA receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in mice
    Ribeiro, RL
    De Lima, TCM
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05): : 861 - 869
  • [42] Recent advances in cannabinoid receptor agonists and antagonists
    Goya, P
    Jagerovic, N
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (10) : 1529 - 1538
  • [43] Therapeutic potential of adenosine receptor antagonists and agonists
    Press, Neil J.
    Gessi, Stefania
    Borea, Pier A.
    Polosa, Riccardo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (08) : 979 - 991
  • [44] MUSCARINIC RECEPTOR SUBTYPES AND THE SELECTIVITY OF AGONISTS AND ANTAGONISTS
    BIRDSALL, NJM
    CURTIS, CAM
    EVELEIGH, P
    HULME, EC
    PEDDER, EK
    POYNER, D
    WHEATLEY, M
    PHARMACOLOGY, 1988, 37 : 22 - 31
  • [45] ORL1 receptor agonists and antagonists
    Judd, A. K.
    Tuttle, D. J.
    Kaushanskaya, A.
    Jones, R. W.
    Sanchez, A.
    Polgar, W.
    Khroyan, T.
    Toll, L.
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 671 - 672
  • [46] Calcium channel and β-receptor antagonists and agonists in MG
    Matell, G
    Bjelak, S
    Jonkers, I
    Pirskanen, R
    Van Vliet, J
    Swerup, C
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 785 - 788
  • [47] NK-2 RECEPTOR AGONISTS AND ANTAGONISTS
    MAGGI, CA
    PATACCHINI, R
    ASTOLFI, M
    ROVERO, P
    GIULIANI, S
    GIACHETTI, A
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 632 : 184 - 191
  • [48] Progesterone Receptor Agonists and Antagonists as Anticancer Agents
    Chakraborty, A.
    Chatterjee, S.
    Roy, P.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (06) : 506 - 517
  • [49] FUNCTIONALIZED CONGENERS OF ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS
    JACOBSON, KA
    DALY, JW
    KIRK, KL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 189 (APR-): : 38 - MEDI
  • [50] ORL1 receptor agonists and antagonists
    Judd, AK
    Tuttle, DJ
    Kaushanskaya, A
    Jones, RW
    Sanchez, A
    Polgae, W
    Khroyan, T
    Toll, L
    BIOPOLYMERS, 2003, 71 (03) : 378 - 378